Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

NCT01269710 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT01269710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01269710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
March 31, 2011
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, bipolar disorder, depressive disorder, not otherwise specified, major depressive disorder, mood disorder, mood disorder, not otherwise specified, prodromal schizophrenia, psychotic disorder, not otherwise specified, schizoaffective disorder, schizophrenia, schizophreniform disorder